Tags : Treatments

M&A

Merck KGaA Acquires AmpTec to Strengthen its mRNA Capabilities for

Shots: The acquisition will integrate AmpTec’s PCR-based mRNA technology with Merck’s expertise in lipids manufacturing, providing combine offering across mRNA value chain The deal will expand Merck’s capabilities to develop & manufacture mRNA for use in vaccines, treatments, and diagnostics applicable in COVID-19 and many other diseases. Additionally, AmpTech’s diagnostic business focusing on customized long […]Read More

Regulatory

Zionexa And Petnet Solutions’ Cerianna (Fluoroestradiol F 18) Receive the

Shots: Cerianna (Fluoroestradiol F 18) is a novel FDA approved molecular imaging agent targeted for PET imaging for detection of estrogen receptor-positive lesions as an adjunct to biopsy in patients with recurrent or metastatic breast cancer The product will also allow the clinicians better guide treatments for metastatic breast cancer patients and improve patients’ QoL […]Read More